| Alexandrea Cromer Broom, NP-C | |
|
22580 Highway 76 E Ste 300, Laurens, SC 29360-8460 | |
| (864) 939-1070 | |
| (864) 939-1079 |
| Full Name | Alexandrea Cromer Broom |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 22580 Highway 76 E Ste 300, Laurens, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003568320 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 25725 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Self Regional Healthcare | Greenwood, SC | Hospital |
| Newberry County Memorial Hospital | Newberry, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Self Medical Group | 6002953916 | 281 |
News Archive
The first evaluation of pharmacists based in accident and emergency departments has concluded that with additional clinical skills, they are able to take on overall clinical responsibility for patients.
More than half of patients with a first episode of psychosis achieve symptomatic remission after 2 years of treatment, but recovery rates are lower, results from a Singaporean study show.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
The U.S. Patent and Trademark Office has issued to Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, patent number 7,784,729 titled "Methods and Compositions for Immunotherapy of Cancer," based upon patent application 10/949,667.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
› Verified 6 days ago
| Entity Name | Self Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982836847 PECOS PAC ID: 6002953916 Enrollment ID: O20091027000071 |
News Archive
The first evaluation of pharmacists based in accident and emergency departments has concluded that with additional clinical skills, they are able to take on overall clinical responsibility for patients.
More than half of patients with a first episode of psychosis achieve symptomatic remission after 2 years of treatment, but recovery rates are lower, results from a Singaporean study show.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
The U.S. Patent and Trademark Office has issued to Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, patent number 7,784,729 titled "Methods and Compositions for Immunotherapy of Cancer," based upon patent application 10/949,667.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexandrea Cromer Broom, NP-C 22580 Highway 76 E Ste 300, Laurens, SC 29360-8460 Ph: (864) 939-1070 | Alexandrea Cromer Broom, NP-C 22580 Highway 76 E Ste 300, Laurens, SC 29360-8460 Ph: (864) 939-1070 |
News Archive
The first evaluation of pharmacists based in accident and emergency departments has concluded that with additional clinical skills, they are able to take on overall clinical responsibility for patients.
More than half of patients with a first episode of psychosis achieve symptomatic remission after 2 years of treatment, but recovery rates are lower, results from a Singaporean study show.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
The U.S. Patent and Trademark Office has issued to Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, patent number 7,784,729 titled "Methods and Compositions for Immunotherapy of Cancer," based upon patent application 10/949,667.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
› Verified 6 days ago
Lorraine M Archer, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 106 Parkview Dr, Laurens, SC 29360 Phone: 864-984-0571 Fax: 864-984-3610 | |
Tiffany Goggans, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 106 Parkview Dr, Laurens, SC 29360 Phone: 864-984-0571 Fax: 864-984-3610 | |
Amy Ledford Strickland, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22580 Highway 76 E Ste 300, Laurens, SC 29360 Phone: 864-939-1070 Fax: 864-939-1079 | |
Cathy L Merrell, F.N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 106 Parkview Dr, Laurens, SC 29360 Phone: 864-984-0571 Fax: 864-984-3610 | |
Mrs. Stephanie Powers Mccall, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 106 Parkview Dr, Laurens, SC 29360 Phone: 864-984-0571 Fax: 864-984-3610 | |
Mrs. Gina Alexander Berrios, APRN, FNP-C, ANP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1108 Church St, Laurens, SC 29360 Phone: 803-924-6093 Fax: 864-682-1234 |